| ■ 영문 제목 : Global Ovarian Cancer Therapeutics Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02256 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 난소암 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (PARP, PD-L1, 혈관 신생 저해제)와 용도별 시장규모 (병원, 연구) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 난소암 치료제 시장 점유율 - 지역별 난소암 치료제 시장규모 - 주요지역의 종류별 시장규모 (PARP, PD-L1, 혈관 신생 저해제) - 주요지역의 용도별 시장규모 (병원, 연구) - 미주의 난소암 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 난소암 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 난소암 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 난소암 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 난소암 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Janssen Pharmaceuticals, Genentech Inc., Astra Zeneca, Boehringer Ingelheim GmbH, Hoffmann La Roche Ltd. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Ovarian Cancer Therapeutics will have significant change from previous year. By the most conservative estimates of global Ovarian Cancer Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1725.9 million in 2020. Over the next five years the Ovarian Cancer Therapeutics market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 2145.2 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Ovarian Cancer Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
PARP
PD-L1
Angiogenesis Inhibitors
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hosptial
Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bristol Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals
Genentech Inc.
Astra Zeneca
Boehringer Ingelheim GmbH
Hoffmann La Roche Ltd.
1 Scope of the Report 2 Executive Summary 3 Ovarian Cancer Therapeutics Market Size by Players 4 Ovarian Cancer Therapeutics by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Ovarian Cancer Therapeutics Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Ovarian Cancer Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of PARP Table 3. Major Players of PD-L1 Table 4. Major Players of Angiogenesis Inhibitors Table 5. Ovarian Cancer Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Ovarian Cancer Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Ovarian Cancer Therapeutics Market Size Market Share by Type (2016-2021) Table 8. Ovarian Cancer Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Ovarian Cancer Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Ovarian Cancer Therapeutics Market Size Market Share by Application (2016-2021) Table 11. Global Ovarian Cancer Therapeutics Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Ovarian Cancer Therapeutics Revenue Market Share by Players (2019-2021E) Table 13. Ovarian Cancer Therapeutics Key Players Head office and Products Offered Table 14. Ovarian Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Ovarian Cancer Therapeutics Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Ovarian Cancer Therapeutics Market Size Market Share by Regions 2016-2021 Table 19. Americas Ovarian Cancer Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Ovarian Cancer Therapeutics Market Size Market Share by Country (2016-2021) Table 21. Americas Ovarian Cancer Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Ovarian Cancer Therapeutics Market Size Market Share by Type (2016-2021) Table 23. Americas Ovarian Cancer Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Ovarian Cancer Therapeutics Market Size Market Share by Application (2016-2021) Table 25. APAC Ovarian Cancer Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Ovarian Cancer Therapeutics Market Size Market Share by Region (2016-2021) Table 27. APAC Ovarian Cancer Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Ovarian Cancer Therapeutics Market Size Market Share by Type (2016-2021) Table 29. APAC Ovarian Cancer Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Ovarian Cancer Therapeutics Market Size Market Share by Application (2016-2021) Table 31. Europe Ovarian Cancer Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Ovarian Cancer Therapeutics Market Size Market Share by Country (2016-2021) Table 33. Europe Ovarian Cancer Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Ovarian Cancer Therapeutics Market Size Market Share by Type (2016-2021) Table 35. Europe Ovarian Cancer Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Ovarian Cancer Therapeutics Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Ovarian Cancer Therapeutics Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Ovarian Cancer Therapeutics Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Ovarian Cancer Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Ovarian Cancer Therapeutics Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Ovarian Cancer Therapeutics Table 44. Key Application and Potential Industries of Ovarian Cancer Therapeutics Table 45. Key Challenges of Ovarian Cancer Therapeutics Table 46. Key Trends of Ovarian Cancer Therapeutics Table 47. Global Ovarian Cancer Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Ovarian Cancer Therapeutics Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Ovarian Cancer Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Ovarian Cancer Therapeutics Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Ovarian Cancer Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Ovarian Cancer Therapeutics Market Size Market Share Forecast by Application (2021-2026) Table 53. Bristol Myers Squibb Company Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 54. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Product Offered Table 55. Bristol Myers Squibb Company Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Bristol Myers Squibb Company Main Business Table 57. Bristol Myers Squibb Company Latest Developments Table 58. Eli Lilly and Company Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 59. Eli Lilly and Company Ovarian Cancer Therapeutics Product Offered Table 60. Eli Lilly and Company Main Business Table 61. Eli Lilly and Company Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Eli Lilly and Company Latest Developments Table 63. GlaxoSmithKline Plc Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 64. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Product Offered Table 65. GlaxoSmithKline Plc Main Business Table 66. GlaxoSmithKline Plc Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. GlaxoSmithKline Plc Latest Developments Table 68. Janssen Pharmaceuticals Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 69. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Product Offered Table 70. Janssen Pharmaceuticals Main Business Table 71. Janssen Pharmaceuticals Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Janssen Pharmaceuticals Latest Developments Table 73. Genentech Inc. Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 74. Genentech Inc. Ovarian Cancer Therapeutics Product Offered Table 75. Genentech Inc. Main Business Table 76. Genentech Inc. Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. Genentech Inc. Latest Developments Table 78. Astra Zeneca Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 79. Astra Zeneca Ovarian Cancer Therapeutics Product Offered Table 80. Astra Zeneca Main Business Table 81. Astra Zeneca Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Astra Zeneca Latest Developments Table 83. Boehringer Ingelheim GmbH Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 84. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Product Offered Table 85. Boehringer Ingelheim GmbH Main Business Table 86. Boehringer Ingelheim GmbH Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Boehringer Ingelheim GmbH Latest Developments Table 88. Hoffmann La Roche Ltd. Details, Company Type, Ovarian Cancer Therapeutics Area Served and Its Competitors Table 89. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Product Offered Table 90. Hoffmann La Roche Ltd. Main Business Table 91. Hoffmann La Roche Ltd. Ovarian Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 92. Hoffmann La Roche Ltd. Latest Developments List of Figures Figure 1. Ovarian Cancer Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Ovarian Cancer Therapeutics Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Ovarian Cancer Therapeutics Market Size Market Share by Type in 2020 Figure 7. Ovarian Cancer Therapeutics in Hosptial Figure 8. Global Ovarian Cancer Therapeutics Market: Hosptial (2016-2021) & ($ Millions) Figure 9. Ovarian Cancer Therapeutics in Research Figure 10. Global Ovarian Cancer Therapeutics Market: Research (2016-2021) & ($ Millions) Figure 11. Global Ovarian Cancer Therapeutics Market Size Market Share by Application in 2020 Figure 12. Global Ovarian Cancer Therapeutics Revenue Market Share by Player in 2020 Figure 13. Global Ovarian Cancer Therapeutics Market Size Market Share by Regions (2016-2021) Figure 14. Americas Ovarian Cancer Therapeutics Market Size 2016-2021 ($ Millions) Figure 15. APAC Ovarian Cancer Therapeutics Market Size 2016-2021 ($ Millions) Figure 16. Europe Ovarian Cancer Therapeutics Market Size 2016-2021 ($ Millions) Figure 17. Middle East & Africa Ovarian Cancer Therapeutics Market Size 2016-2021 ($ Millions) Figure 18. Americas Ovarian Cancer Therapeutics Market Size Market Share by Country in 2020 Figure 19. Americas Ovarian Cancer Therapeutics Market Size Market Share by Type in 2020 Figure 20. Americas Ovarian Cancer Therapeutics Market Size Market Share by Application in 2020 Figure 21. United States Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 22. Canada Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 23. Mexico Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 24. APAC Ovarian Cancer Therapeutics Market Size Market Share by Regions in 2020 Figure 25. APAC Ovarian Cancer Therapeutics Market Size Market Share by Type in 2020 Figure 26. APAC Ovarian Cancer Therapeutics Market Size Market Share by Application in 2020 Figure 27. China Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 28. Japan Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 29. Korea Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 30. Southeast Asia Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 31. India Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 32. Australia Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 33. Europe Ovarian Cancer Therapeutics Market Size Market Share by Country in 2020 Figure 34. Europe Ovarian Cancer Therapeutics Market Size Market Share by Type in 2020 Figure 35. Europe Ovarian Cancer Therapeutics Market Size Market Share by Application in 2020 Figure 36. Germany Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 37. France Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 38. UK Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 39. Italy Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 40. Russia Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 41. Middle East & Africa Ovarian Cancer Therapeutics Market Size Market Share by Region in 2020 Figure 42. Middle East & Africa Ovarian Cancer Therapeutics Market Size Market Share by Type in 2020 Figure 43. Middle East & Africa Ovarian Cancer Therapeutics Market Size Market Share by Application in 2020 Figure 44. Egypt Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 45. South Africa Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 46. Israel Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 47. Turkey Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 48. GCC Country Ovarian Cancer Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 49. Americas Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 50. APAC Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 51. Europe Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 52. Middle East & Africa Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 53. United States Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 54. Canada Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 55. Mexico Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 56. Brazil Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 57. China Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 58. Japan Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 59. Korea Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 60. Southeast Asia Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 61. India Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 62. Australia Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 63. Germany Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 64. France Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 65. UK Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 66. Italy Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 67. Russia Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 68. Spain Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 69. Egypt Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 70. South Africa Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 71. Israel Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 72. Turkey Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) Figure 73. GCC Country Ovarian Cancer Therapeutics Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 난소암 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02256) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 난소암 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |